Clinical Trials Logo

Clinical Trial Summary

Human milk (HM) is considered the gold standard nutrient for infants, which contains a lot of beneficial nutrients such as prebiotics and lactoferrin. Previous studies have shown that both prebiotics and lactoferrin play important roles in generating a bifidobacteria-dominated colonic microflora.The purpose of this study is to investigate the stool characteristics,acceptability, and gastrointestinal tolerance in term infants fed a starting infant formula supplemented with prebiotics and lactoferrin.


Clinical Trial Description

Human milk (HM) is considered the gold standard nutrient for infants, which contains a lot of beneficial nutrients such as prebiotics and lactoferrin. Previous studies have shown that both prebiotics and lactoferrin play important roles in generating a bifidobacteria-dominated colonic microflora as well as the intestinal immune systems. The purpose of this study is to investigate the stool characteristics(including intestinal microbiota) acceptability, and gastrointestinal tolerance in infants fed a starting infant formula supplemented with prebiotics and lactoferrin, and compared these data with infants on exclusively breast feeding. ;


Study Design

Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label


Related Conditions & MeSH terms


NCT number NCT02363582
Study type Interventional
Source Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Contact Jiang Wu, MD
Phone 86 21 25078999
Email eureka_wz@126.com
Status Recruiting
Phase N/A
Start date June 2014
Completion date June 2015

See also
  Status Clinical Trial Phase
Recruiting NCT03178474 - Efficacy of JINLINGGUAN and TOFER Formula in Formula-fed Chinese Term Infants N/A
Completed NCT02431377 - Acceptability and GI Tolerance of an Alpha-lactalbumin-enriched Formula N/A